Logo

Molecular Devices Shares Up 10 Percent on Stock Upgrade

Jul 25, 2006
NEW YORK (GenomeWeb News) – Shares in Molecular Devices were up around 10 percent, or $2.17, to $24.39 in mid-afternoon trading today after an investment bank yesterday upgraded its stock.
 
Infinium Securities upgraded the stock to “Outperform” from “Underperform” yesterday.
 
The uptick today halted a 16-percent decline in share price that began July 21 when Molecular Devices announced weak second quarter revenue and earnings.

Breaking News
The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.